CUREOSCITY TECHNOLOGIES LIMITED - Profile & Financials

Accounts Submitted

Confirmation Statement Submitted

Net assets £-1.74M £849.00K 2023 year on year

Total assets £1.35M £254.00K 2023 year on year

Total Liabilities £3.10M £595.00K 2023 year on year

Charges 2

2 outstanding

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

33 Margaret Street London W1G 0JD United Kingdom

Office ()

London, England, United Kingdom, Europe

Telephone

0(0)2039206859

info@cureoscity.com

Website

cureoscity.com

Credit Report

Discover CUREOSCITY TECHNOLOGIES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2021–2023)

Cash in Bank

£71.00k

Increased by £25.00k (+54%)

Net Assets

-£1.74M

Decreased by £849.00k (-95%)

Total Liabilities

£3.10M

Increased by £595.00k (+24%)

Turnover

£1.32M

Increased by £760.00k (+135%)

Employees

N/A

Decreased by 21 (-100%)

Debt Ratio

229%

Increased by 73 (+47%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

1 Allotment 2,881 Shares £28.81 Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
2 Feb 2022	B ORDINARY	2,881	£28.81	£0.01

Officers

3 active 6 resigned

Show resigned officers

						Status
Deborah Chun	Director	American	United States	65	24 Feb 2025	Active
Nicola Sarah Jane Mcnish	Director	British	England	62	24 Feb 2025	Active
Rupert Levy	Director	British	England	39	24 Feb 2025	Active

Shareholders

Shareholders (9)


Martin Peterlechner	1.3%	166	Ordinary B	19 Feb 2024
Sam Strawbridge	0.6%	83	Ordinary B	19 Feb 2024
Peter Davies	0.6%	83	Ordinary B	19 Feb 2024

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Grosvenor Hill Ventures Limited

United Kingdom

Active

Notified 30 Nov 2021

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors

Swiftconnect Inc.

United States Of America

Active

Notified 24 Feb 2025

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 50 To 75 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

SWIFTCONNECT INC. united states of america

GROSVENOR HILL VENTURES LIMITED united kingdom voting rights 75 to 100 percent

SAVILLS PLC united kingdom

CUREOSCITY TECHNOLOGIES LIMITED Current Company

Charges

2 outstanding

Documents

Company Filings

Date	Category	Description	Document
7 Mar 2025	Incorporation	Memorandum Articles	View(27 pages)
7 Mar 2025	Capital	Capital Return Purchase Own Shares	View(4 pages)
7 Mar 2025	Resolution	Resolutions	View(1 page)
7 Mar 2025	Resolution	Resolutions	View(1 page)
5 Mar 2025	Officers	Appointment of Rupert Levy as director on 2025-02-24	View(2 pages)